GlassScriptPhysician profile
Mark Robert Anderson
NPI 1922156181
$9,465.40
in general payments reported to CMS, 2019-2025
29 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $322 · 2021: $4,763 · 2022: $1,935 · 2023: $1,489 · 2024: $423 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269 · Travel and Lodging: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.24 |
| Travel and Lodging | $849.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,047.29 | 2021-2024 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $2,333.34 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Teleflex LLC | $1,289.42 | 2020-2024 | Urolift |
| Olympus America INC. | $448.52 | 2022-2024 | Cysto-Nephro Videoscope, Bovie, Itind System |
| Astellas Pharma US INC | $425.91 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $289.86 | 2019-2022 | |
| Pfizer INC. | $184.41 | 2019-2022 | |
| Agiliti Surgical, INC. | $183.98 | 2025 | Olympus Soltive Tfl Laser |
| Janssen Biotech, INC. | $152.35 | 2021-2022 | |
| Urovant Sciences INC | $146.18 | 2021-2022 | |
| Myovant Sciences INC. | $124.42 | 2021-2022 | |
| Blue Earth Diagnostics | $117.34 | 2019-2022 | |
| Palette Life Sciences, INC. | $102.61 | 2022 | |
| Myriad Genetic Laboratories, INC. | $94.92 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $66.79 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $54.94 | 2021-2022 | |
| Urogen Pharma, INC. | $52.84 | 2021-2022 | |
| Photocure INC | $43.11 | 2019-2020 | |
| Healthtronics Stone Solutions, LLC | $41.96 | 2019 | |
| Boston Scientific Corporation | $39.19 | 2020-2022 | |
| Coloplast Corp | $36.82 | 2021 | |
| Abbvie INC. | $33.83 | 2020-2021 | |
| Rochester Medical Corporation | $33.11 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.97 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $26.12 | 2021 | |
| Allergan, INC. | $19.31 | 2021 | |
| Smith+Nephew, INC. | $17.94 | 2020 | |
| Abbott Laboratories | $16.19 | 2019 | |
| Neotract INC. | $15.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.